SPECIMEN REPORT · NOTHING HELD BACK

Read the deliverable before you buy it.

This is a complete audit report, start to finish, on a real listing from our scan database. The brand is redacted because we never name a failing brand publicly. Everything else is exactly what a client receives: every failing claim quoted from their own copy, the rule it breaks, and the rewrite that replaces it.

What this is: a specimen, built from a stress-support listing our engine ruled during the database build. It shows the format, the reasoning and the rewrites a paying client receives. It is not a client engagement, and no client's file is ever published.
CLAIMS AUDIT REPORT · SPECIMEN FORM CV-AR
PRODUCT[redacted] · cortisol and stress-support supplement, Amazon listing
SURFACES IN THIS SPECIMENAmazon listing: title, bullets, A+ content. A full audit also covers your website, ad copy, email flows, label and what the AI assistants say about you.
RULED AGAINSTAll 81 published Claims Verified standards, drawn from FDA, FTC, Health Canada, Amazon and Meta rules
1 · VERDICT
FAIL RISK SCORE 100 · TOP DECILE OF 1,149 RULED LISTINGS

2 Critical · 5 High · 0 Medium. The Critical findings are disease-claim class, the category Amazon's automated enforcement and FDA warning letters act on first.

2 · FINDINGS
01 · CRITICAL · NAMED CONDITION SOURCE: A+ CONTENT
AS PUBLISHED
“Thyroid Support Complex”
COMPLIANT REWRITE
“Supports healthy thyroid function”

RULING  Naming thyroid support alongside disease-adjacent framing implies treatment of thyroid disease, which reclassifies the product as an unapproved drug.

02 · CRITICAL · PLATFORM POLICY SOURCE: BULLET 4
AS PUBLISHED
“adrenal fatigue supplements”
COMPLIANT REWRITE
“Remove the disease term, describe it as a stress-support supplement”

RULING  Adrenal fatigue is a named condition used here as a keyword. It triggers Amazon automated disease-term detection and implies treatment of a medical condition.

03 · HIGH · IMPLIED DRUG SOURCE: BULLET 1
AS PUBLISHED
“regulate cortisol”
COMPLIANT REWRITE
“Supports healthy cortisol levels already within the normal range”

RULING  Regulate implies pharmacological control over a hormone, which reads as a drug-like mechanism claim.

04 · HIGH · IMPLIED DRUG SOURCE: BULLET 1
AS PUBLISHED
“cortisol balance”
COMPLIANT REWRITE
“Supports healthy hormone levels”

RULING  Balance implies correcting a pathological imbalance rather than supporting normal function.

05 · HIGH · IMPLIED DRUG SOURCE: BULLET 3
AS PUBLISHED
“immune-boosting”
COMPLIANT REWRITE
“Supports healthy immune function”

RULING  Boost implies enhancement beyond normal immune function, a phrase the FDA has cited in warning letters.

06 · HIGH · NAMED CONDITION SOURCE: A+ CONTENT
AS PUBLISHED
“Menopause Supplement”
COMPLIANT REWRITE
“Supports hormonal balance through life stages”

RULING  Naming menopause as the condition the product addresses implies a symptom-treatment claim.

07 · HIGH · IMPLIED DRUG SOURCE: TITLE
AS PUBLISHED
“Plant-Based Hormone Balance”
COMPLIANT REWRITE
“Supports healthy hormone levels”

RULING  Balance in a hormone context implies correction of a pathological imbalance rather than support of normal function.

3 · WHAT HAPPENS NEXT

Every flagged claim above has a rewrite you can paste straight into Seller Central. Fix Critical findings first, they are the takedown triggers, then High for ad-approval and substantiation risk, then Medium. We can implement every rewrite for you, $500 flat, two business days.

Listings drift. Agencies push new copy, A+ modules change, a seasonal ad reintroduces a phrase the audit cleared out. Monitoring re-scans every surface monthly and includes one re-review. Remediate to a pass and your charter place for the Mark locks at the founding rate that day.

4 · SIGN-OFF BLOCK

Every delivered report closes with this block, signed by the reviewer of record. On a specimen it stays unsigned: no client file, no signature.

Independent pharmacist review: Reviewed by [reviewer of record], PharmD, licensed pharmacist, independent review of marketing-claims findings under the published Claims Verified rubric. Licence on file, verifiable on the public register on request.
Signature: ________________________   Date: ______________

This one failed. A pass looks different.

Roughly a third of the listings we have ruled come back clean or close to it. A passing report is shorter: the verdict, the surfaces we read, anything Medium worth tidying, and the signed confirmation that nothing Critical was found. That document is the point. It is what a retail buyer, an ad reviewer or a payment processor accepts when they ask whether anyone has checked, and it is what locks your charter place for the Mark at the founding rate on the day you pass.

Want this on your own listing?

$2,000 flat  ·  five business days
• Every surface you publish, not just the one shown here: Amazon, website, ad copy, email flows, label and what the AI assistants tell shoppers about you
• Every finding severity-rated, quoted from your own copy, with a rewrite that keeps the sales promise
• Pharmacist-signed, so the file answers Amazon appeals, ad-platform review and payment-processor underwriting
• Pass, and your charter place for the Mark locks that day

Review of marketing language only, not product testing, formulation, facility compliance, or legal advice. Findings are our professional opinion under the published Claims Verified rubric, based on listing copy as captured on the scan date.

Request an audit · $2,000